News | Reading Time 3 minutes
Health Canada confirms Lallemand Health Solutions’ strain L. plantarum Rosella can support female health by vaginal application
Lallemand Health Solutions is pleased to announce that Health Canada has officially recognized the efficacy of probiotic strain, L. plantarum Rosella[1], in supporting women’s health by vaginal application[2]. This confirmation opens new possibilities for Canadian women seeking natural solutions for their intimate well-being.
Health Canada has granted specific health claims for L. plantarum Rosella:
- Support vaginal/female health by vaginal application;
- Helps support a healthy vaginal microflora;
- Maintains vaginal microbiome health;
- Reduce vaginal pH to healthy levels;
In combination with antifungal treatment, help delay/lengthen/improve relapse time for (recurrent) vulvovaginal candidiasis (VVC/rVVC). - In combination with antifungal treatment, reduces clinical signs (itching, burning, pain during sexual intercourse, pain while urinating, vaginal discharge, smell, redness, swelling) of vulvovaginal candidiasis (VVC)/recurrent vulvovaginal candidiasis (rVVC).
- Helps to improve vaginal (microbiome) health in women with a history of vulvovaginal candidiasis (VVC)/recurrent vulvovaginal candidiasis (rVVC).
- Reduces clinical signs (redness, swelling) of vulvovaginal candidiasis (VVC)/ recurrent vulvovaginal candidiasis (VVC).
- Helps in recurrent vulvovaginal candidiasis (rVVC).
- Helps treat recurrent vulvovaginal candidiasis (rVVC) as an adjuvant to antimicrobial.
These come in addition to the successful orally administered probiotic L. plantarum Rosella being already offered by Lallemand Health Solutions in Asia, Americas, France and Czech Republic, at a different dose and as supported by previously approved Canadian health claims[3].
About Rosella
L. plantarum Rosella is a unique strain, with mechanistic and clinical evidence, extensively studied worldwide in over 800 women, in six clinical studies, including two by oral intake and four by vaginal applications making it one of the most documented probiotic strains in women’s health. These studies demonstrate its effectiveness to promotes vaginal health and as an adjunct to conventional treatments (anti-fungal), to help manage vulvovaginal candidiasis (VVC) or bacterial vaginosis (BV), depending on the intended use and dose, as vaginal administration or oral intake. Its versatility makes it a convenient choice for women seeking intimate health support, from helping to maintain proper vaginal balance, to being used for recurrent Vulvovaginal Candidiasis.
“Probiotics are increasingly attracting women seeking self- care for their intimate health. A unique probiotic like Rosella represents a significant step forward in supporting women’s intimate health, offering a range of benefits, from maintenance of health to a natural alternative to address vaginal concerns, especially recurrent Vulvovaginal Candidiasis, when applied locally. It is really nice to see that Canadian authorities have recognized its efficacy, both orally and as a vaginal application We believe that these approved health claims will empower Canadian women to make informed choices and hopefully, to prioritize their well-being.” explains Solange Henoud, Vice-president Regulatory and Compliance.
About Lallemand Health Solutions – Leading Probiotics Forward.
With 90 years of know-how, Lallemand Health Solutions, a global leader of the probiotic industry, specializes in the development, production, and marketing of bacteria- and yeast-based probiotic supplements for human health, food applications and nutricosmetics.
MEDIA CONTACT
Marilou Luneau, Communications Manager, Lallemand Health Solutions mluneau@lallemand.com
[1] L. plantarum P17630 (Proge P17630®), ROSELLA, licensed from PROGE FARM®, Italy
[2] NPN-80129827
[3] Source of probiotics; Helps support female or vaginal health; Helps support a healthy vaginal microflora; Maintains a healthy vaginal microbiome
Published Apr 19, 2024 | Updated May 2, 2024